Matt Wiley is listed as an executive officer on 1 SEC Form D filing by 1 issuer in May 2025: Mind Medicine (MindMed) Inc. (New York, NY — pharmaceuticals — 2025; $75M reported sold to 2 investors).
What this means One deal on file with the SEC, filed May 2025. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Andreas Krebs (1 shared filing), Carol A. Vallone (1 shared filing), Carrie Liao (1 shared filing), Daniel Karlin (1 shared filing), David Gryska (1 shared filing) and 4 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Matt. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for Matt Wiley and found 1 difference, 1 worth asking the sponsor about: Form D filed 633 days after the first sale.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.